《Journal Of Infection And Chemotherapy》雜志的最新年發文量為198篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在傳染病學領域的學術影響力。
該刊聚焦于醫學-傳染病學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 一般,3-8周 。
Journal Of Infection And Chemotherapy 雜志發文統計
文章名稱引用次數
- Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents13
- Trends and patterns of national antimicrobial consumption in Japan from 2004 to 201612
- Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan12
- Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus11
- Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy11
- Sites of infection associated with Streptococcus anginosus group among children10
- Risk factors for surgical site infection after major hepatobiliary and pancreatic surgery10
- Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan9
- Mortality and risk factor analysis for Candida blood stream infection: A multicenter study9
- Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan9
國家/地區發文量
- Japan567
- USA30
- CHINA MAINLAND29
- South Korea14
- Italy8
- Saudi Arabia7
- GERMANY (FED REP GER)6
- Turkey6
- Australia5
- Belgium5
